Carter Worth, Worth Charting, talks technicals on Morgan Stanley and Novo Nordisk.
Source link
Trending
- 'Fast Money' traders talk stocks climbing on hopes tariffs will ease
- South Korea prosecutors indict ex-president Moon Jae-in for bribery
- We are still short on planes and engines, says Korean Air Chairman
- Will Canada’s Next Prime Minister Solve the Million-Dollar Housing Crisis?
- 'Whole host of other factors' outside of tariffs driving volatility, says CME Group's Terry Duffy
- GE Vernova CEO describes huge electricity demand in the U.S.
- Korea GDP, SK Hynix, U.S.-China trade
- What’s likely to move the market
Chart Master: Sell Morgan Stanley, buy Novo Nordisk?
